Advances in Antiretroviral Therapy -- Drug Discovery to Global Strategy From CROI 2004: Douglas Ward, MD, provides an overview of where we are now, and where we need to go, with respect to globally ...
Merck's HIV pill met key efficacy and safety goals in Phase 3 trials, matching Biktarvy as the FDA reviews its application with a 2026 decision date.
In a landmark moment for the fight against AIDS, a breakthrough study finds that antiretroviral therapy (ART) stops the spread of HIV. “What this study really shows is that risk of transmission is ...
Merck said on Wednesday its experimental oral HIV medicine was found to be non-inferior to Gilead Sciences' top-selling drug ...
Merck reports positive results from phase 3 trial of once-daily, oral, two-drug, single-tablet regimen of Doravirine/Islatravir in treatment-naïve adults with HIV-1 infection ...
Aadia Rana, M.D., professor of medicine in the Division of Infectious Diseases at the University of Alabama at Birmingham, senior scientist with the UAB Center for AIDS Research and study chair for ...
Continued antiretroviral therapy was found to be safe and beneficial in HIV-positive postpartum women with high CD4+ T cell counts. A study recently published in PLoS One found continued ...
Weight gain can be a somewhat unexpected result of treatment for HIV. Add that to the complicated feelings you may already have about being positive, and you could find yourself struggling with your ...
Enacting Medicaid expansion in Texas and increasing the use of preventive and antiviral medications could result in a decline of new HIV infections among young Black gay, bisexual, and other men who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback